Shionogi & Co logo

4507 - Shionogi & Co News Story

¥6043 -33.0  -0.5%

Last Trade - 07/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £13.23bn
Enterprise Value £10.73bn
Revenue £2.25bn
Position in Universe 67th / 3862

BRIEF-Shionogi Accelerates Development Of Potential Covid-19 Treatments And Vaccine

Tue 28th April, 2020 1:46pm
April 28 (Reuters) - Shionogi & Co Ltd  4507.T :
    * SHIONOGI ACCELERATES DEVELOPMENT OF POTENTIAL COVID-19
TREATMENTS AND VACCINE
    * SHIONOGI - INITIATED COLLABORATIVE RESEARCH TO IDENTIFY
DRUGS
ACTIVE AGAINST COVID-19 WITH HOKKAIDO UNIVERSITY RESEARCH CENTER
FOR ZOONOSIS CONTROL
    * SHIONOGI - ACCELERATING COVID-19 DRUG DISCOVERY EFFORTS
WITH AIM
OF STARTING CLINICAL TRIALS LATER THIS YEAR
    * SHIONOGI - PLANS TO START CLINICAL TRIALS IN JAPAN WITHIN
YEAR
FOR A RECOMBINANT PROTEIN VACCINE FOR COVID-19

Source text for Eikon:  ID:nBw4Q5WhDa 
Further company coverage:  4507.T 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.